Nanocarrier-based topical drug delivery for the treatment of skin diseases

Bibliography

• Sigmundsdottir H. Improving topical treatments for skin Diseases. Trends Pharmacol Sci 2010;31:239-45
   PubMed Web of Science ®Google Scholar
• Fleischer AB Jr, Feldman SR, Rapp SR. The magnitude of skin disease in the United States. Dermatol Clin 2000;18:xv-xxi
   PubMed Web of Science ®Google Scholar
• Dawson AL, Robert PD, Dirk ME. Infectious skin diseases: a review and needs assessment. Dermatol Clin 2012;30:141-51
   PubMed Web of Science ®Google Scholar
• Roberts MS, Walters KA. Human skin morphology and dermal absorption. In: Roberts MS, Walters KA, editors. Dermal Absorption and Toxicity Assessment. Informa Healthcare, New York; 2008. p. 1-15
   Google Scholar
• Bissett DL. Anatomy and biochemistry of the skin. In: Kydonieus F, Berner B, editors. Transdermal Delivery of Drugs. Volume 1 CRC Press, Inc., Boca Raton; 1987. p. 29-42
   Google Scholar
• Erdogan S. Liposomal nanocarriers for tumor imaging. J Biomed Nanotechnol 2009;5:141-50
   PubMed Web of Science ®Google Scholar
• Bouwstra JA, Honeywell-Nguyen PL. Skin structure and mode of action of vesicles. Adv Drug Deliv Rev 2002;54:41-55
   PubMed Web of Science ®Google Scholar
• Prow TW, Grice JE, Lin LL, Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev 2011;63:470-91
   PubMed Web of Science ®Google Scholar
• Merwe D, van der, Brooks JD, Gehring R, A physiologically based pharmacokinetic model of organophosphate dermal absorption. Toxicol Sci 2006;89:188-204
   PubMed Web of Science ®Google Scholar
• Langbein L, Grund C, Kuhn C, Tight junctions and compositionally related junctional structures in mammalian stratified epithelia and cell cultures derived there from. Eur J Cell Biol 2002;81:419-35
   PubMed Web of Science ®Google Scholar
• Schaefer H, Redelmeier TE. Skin Barrier: Principles of Percutaneous Absorption. Karger, Basel; 1996
   Google Scholar
• Barry BW. Dermatological Formulations: Percutaneous Absorption. Marcel Dekker, New York; 1983
   Google Scholar
• Suzanne MB, Zhi D, Elly R, Advances in transcutaneous vaccine delivery: do all ways lead to Rome? J Control Release 2010;148:266-82
   PubMed Web of Science ®Google Scholar
• Robert EM, Kalia YN. New developments in topical antifungal therapy. Am J Drug Deliv 2006;4:231-47
   Google Scholar
• Gabard B, Elsner P, Surber C, Treffel P. Dermatopharmacology of Topical Preparations: a Product-Development Oriented Approach. Springer-Verlag, Berlin; 2000
   Google Scholar
• Dancik Y, Jepps OG, Roberts MS. Beyond stratum corneum. In: Roberts MS, Walters KA, editors. Dermal Absorption and Toxicity Assessment. Informa Healthcare, Inc., New York; 2008. p. 209-50
   Google Scholar
• Garcia OP, Hansen SH, Shah VP, Impact of adult atopic dermatitis on topical drug penetration: assessment by cutaneous microdialysis and tape stripping. Acta Derm Venereol 2009;89:33-8
   PubMed Web of Science ®Google Scholar
• Jensen LB, Petersson K, Nielsen HM. In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin. Eur J Pharm Biopharm 2011;79:68-75
   PubMed Web of Science ®Google Scholar
• Nacht S, Katz M. The microsponge: A novel topical programmable delivery system. In: Osborne DW, Amman AH, editors. Topical Drug Delivery Formulations. Marcel Dekker Basel, New York; 1990. p. 299-325
   Google Scholar
• Pradhan SK. Microsponges as the versatile tool for drug delivery system. Int J Res Pharm Chem 2011;1:243-58
   Google Scholar
• Barry BW. Penetration enhancers. In: Shroot B, Schafer H, editors. Skin Pharmacokinetics. Karger, Basel; l987. p. 121-7
   Google Scholar
• Schmid MH, Korting HC. Therapeutic progress with topical liposome drugs for skin disease. Adv Drug Deliv Rev 1996;18:335-42
   Web of Science ®Google Scholar
• Teichmann A, Heuschkel S, Jacobi U, Comparison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion and an amphiphilic cream. Eur J Pharm Biopharm 2007;66:159-64
   PubMed Web of Science ®Google Scholar
• Castro GA, Coelho ALLR, Oliveira CA, Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles. Int J Pharm 2009;381:77-83
   PubMed Web of Science ®Google Scholar
• Gupta M, Vyas SP. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phys Lipids 2012. doi:10.1016/j.chemphyslip.2012.01.006
   PubMedGoogle Scholar
• Pople PV, Singh KK. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus. Eur J Pharm Biopharm 2011;79:82-94
   PubMed Web of Science ®Google Scholar
• Bawarski WE, Chidlowsky E, Bharali DJ, Mousa SA. Emerging nanopharmaceuticals. Nanomed Nanotechnol Biol Med 2008;4:273-82
   PubMed Web of Science ®Google Scholar
• Zhang L, Pornpattananangkul D, Hu CMJ, Huang CM. Development of nanoparticles for antimicrobial drug delivery. Curr Med Chem 2010;17:585-94
   PubMed Web of Science ®Google Scholar
• Katahira N, Murakami T, Kugai S, Enhancement of topical delivery of a lipophilic drug from charged multilamellar liposomes. J Drug Target 1999;6:405-14
   PubMed Web of Science ®Google Scholar
• Martin P, Youenang P, Daniel K, Simon B. Positively and negatively charged submicron emulsions for enhanced topical delivery of antifungal drugs. J Control Release 1999;58:177-87
   PubMed Web of Science ®Google Scholar
• Vanniasinghe AS, Bender V, Manolios N. The potential of liposomal drug delivery for the treatment of inflammatory arthritis. Semin Arthritis Rheum 2009;39:182-96
   PubMed Web of Science ®Google Scholar
• Tamilvanan S, Venkateshan N, Ludwig A. The potential of lipid-and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections. J Control Release 2008;128:2-22
   PubMed Web of Science ®Google Scholar
• Schreier H, Bouwstra J. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Release 1994;30:l-15
   Web of Science ®Google Scholar
• Gupta M, Goyal AK, Paliwal SR, Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis. J Liposome Res 2010;20:341-50
   PubMed Web of Science ®Google Scholar
• Mezei M, Gulasekharam V. Liposomes – a selective drug delivery system for the topical route of administration: lotion dosage form. Life Sci 1980;26:1473-7
   PubMed Web of Science ®Google Scholar
• Trapasso E, Cosco D, Celia C, Retinoids: new use by innovative drug-delivery systems. Expert Opin Drug Deliv 2009;5:465-83
   Google Scholar
• Kirjavainen M, Urtti A, Jaaskelainen I, Interaction of liposomes with human skin in vitro – the influence of lipid composition and structure. Biochim Biophys Acta 1996;1304:179-89
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Williams AC, Barry BW. Can drug bearing liposomes penetrate intact skin? J Pharm Pharmacol 2006;58:415-29
   PubMed Web of Science ®Google Scholar
• Skalko N, Cajkovac M, Jalsenjak I. Liposomes with clindamycin hydrochloride in therapy of acne vulgaris. Int J Pharm 1992;85:97-101
   Web of Science ®Google Scholar
• Tabbakhian M, Tavakoli N, Jaafari MR, Daneshamouz S. Enhancement of follicular delivery of finasteride by liposomes and niosomes: in vitro permeation and in vivo deposition studies using hamster flank and ear models. Int J Pharm 2006;323:1-10
   PubMed Web of Science ®Google Scholar
• Montenegro L, Panico AM, Ventimiglia A, Bonina FP. In vitro retinoic acid release and skin permeation from different liposome formulations. Int J Pharm 1996;133:89-96
   Web of Science ®Google Scholar
• Sinico C, Manconi M, Peppi M, Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle–skin interaction. J Control Release 2005;103:123-36
   PubMed Web of Science ®Google Scholar
• Cevc G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst 1996;13:257-388
   PubMed Web of Science ®Google Scholar
• Honeywell-Nguyen PL, Bouwstra JA. Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol 2005;2:67-74
   PubMedGoogle Scholar
• Trotta M, Peira E, Carlotti ME, Gallarate M. Deformable liposomes for dermal administration of methotrexate. Int J Pharm 2004;270:119-25
   PubMed Web of Science ®Google Scholar
• Boinpally RR, Zhou SL, Poondru S, Lecithin vesicles for topical delivery of diclofenac. Eur J Pharm Biopharm 2003;56:389-92
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, transfersomes. Biochim Biophys Acta 2001;1514:191-205
   PubMed Web of Science ®Google Scholar
• Elsayed MAA, Abdallah OY, Naggar VF, Khalafallah NM. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 2007;332:1-16
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Williams AC, Barry BW. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro. J Pharm Pharmacol 2001a;53:1069-77
   PubMed Web of Science ®Google Scholar
• Trotta M, Peira E, Debernardi F, Gallarate M. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm 2002;241:319-27
   PubMed Web of Science ®Google Scholar
• Touitou E, Dayan N, Bergelson L, Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 2000;65:403-18
   PubMed Web of Science ®Google Scholar
• Liu J, Hu G. Advances in studies of phospholipids as carriers in skin topical application. J Nanjing Med Uni 2007;21:349-53
   Google Scholar
• Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001;14:101-14
   PubMed Web of Science ®Google Scholar
• Godin B, Touitou E. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J Control Release 2004;94:365-79
   PubMed Web of Science ®Google Scholar
• Paolino D, Lucania G, Mardente D, Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release 2005;106:99-110
   PubMed Web of Science ®Google Scholar
• Manconi M, Sinico C, Caddeo C, Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. Int J Pharm 2011;412:37-46
   PubMed Web of Science ®Google Scholar
• Mura S, Manconi M, Sinico C, Transcutol containing vesicles for topical delivery of minoxidil. J Drug Target 2011;19:189-96
   PubMed Web of Science ®Google Scholar
• Song CK, Balakrishnan P, Shim C, A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids Surf B Biointerfaces 2012;1:299-304
   Google Scholar
• Bird DK, Schneider AL, Watkinson AC, Navigating transdermal diffusion with multiphoton fluorescence lifetime imaging. J Microsc 2008;230:61-9
   PubMed Web of Science ®Google Scholar
• Barbara G, Van GM, Sien B, Stefaan C. Flexible nanosomes (SECosomes) enable efficient siRNA delivery in cultured primary skin cells and in the viable epidermis of ex vivo human skin. Adv Funct Mater 2010;20:4077-90
   Web of Science ®Google Scholar
• Shah AK, Date AA, Joshi MD, Patraval VB. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm 2007;345:163-71
   PubMed Web of Science ®Google Scholar
• Gupta M, Tiwari S, Vyas SP. Influence of various lipid core on characteristics of SLNs designed for topical delivery of fluconazole against cutaneous candidiasis. Pharm Dev Technol 2011; doi:10.3109/10837450.2011.598161
   Web of Science ®Google Scholar
• Mandawgade SD, Patravale VB. Development of SLNs from natural lipids: application to topical delivery of tretinoin. Int J Pharm 2008;363:132-8
   PubMed Web of Science ®Google Scholar
• Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur J Pharm Biopharm 2000;50:161-77
   PubMed Web of Science ®Google Scholar
• Pardeike J, Hommoss A, Muller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009;366:170-84
   PubMed Web of Science ®Google Scholar
• Souto EB, Wissing SA, Barbosa CM, Muller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004;278:71-7
   PubMed Web of Science ®Google Scholar
• Souto EB, Muller RH. SLN and NLC for topical delivery of ketoconazole. J Microencapsul 2005;22:501-10
   PubMed Web of Science ®Google Scholar
• Joshi M, Patravale V. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int J Pharm 2008;346:124-32
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Boonme P, Souto EB, Influence of oil content on physicochemical properties and skin distribution of nile red-loaded NLC. J Control Release 2008;128:134-41
   PubMed Web of Science ®Google Scholar
• Stecova J, Mehnert W, Blaschke T, Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. Pharm Res 2007;24:991-1000
   PubMed Web of Science ®Google Scholar
• Wiedersberg S, Leopold CS, Guy RH. Bioavailability and bioequivalence of topical glucocorticoids. Eur J Pharm Biopharm 2008;68:453-66
   PubMed Web of Science ®Google Scholar
• Santos MC, Mehnert W, Schaller M, Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target 2002;10:489-95
   PubMed Web of Science ®Google Scholar
• Hu FQ, Jiang SP, Du YZ, Preparation and characteristics of monostearin nanostructured lipid carriers. Int J Pharm 2006;314:83-9
   PubMed Web of Science ®Google Scholar
• Sivaramakrishnan R, Nakamura C, Mehnert W, Glucocorticoid entrapment into lipid carriers characterization by parelectric spectroscopy and influence on dermal uptake. J Control Release 2004;97:493-502
   PubMed Web of Science ®Google Scholar
• Wissing S, Lippacher A, Muller A. Investigations on the occlusive properties of solid lipid nanoparticles (SLN). J Cosmet Sci 2001;52:313-24
   PubMed Web of Science ®Google Scholar
• Fang JY, Fang C, Liu C-H, Su Y-H. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 2008;70:633-40
   PubMed Web of Science ®Google Scholar
• Shah PP, Desai PR, Patel AR, Singh MS. Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs. Biomaterials 2012;33:1607-17
   PubMed Web of Science ®Google Scholar
• Senyigit T, Sonvico F, Barbieri S, Lecithin/Chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin. J Control Release 2010;142:368-73
   PubMed Web of Science ®Google Scholar
• Alvarez-Roman R, Naik A, Kalia YN, Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res 2004;21:1818-25
   PubMed Web of Science ®Google Scholar
• Luengo J, Weiss B, Schneider M, Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol Physiol 2006;19:190-7
   PubMed Web of Science ®Google Scholar
• Samah NA, Williams N, Heard CM. Nanogel particulates located within diffusion cell receptor phases following topical application demonstrates uptake into and migration across skin. Int J Pharm 2010;401:72-8
   PubMed Web of Science ®Google Scholar
• Batheja P, Sheihet L, Kohn J, Topical drug delivery by a polymeric nanosphere gel: formulation optimization and in vitro and in vivo skin distribution studies. J Control Release 2011;149:159-67
   PubMed Web of Science ®Google Scholar
• Abdel-Mottaleb MMA, Neumann D, Lamprecht A. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers. Eur J Pharm Biopharm 2011;79:36-42
   PubMed Web of Science ®Google Scholar
• Bachhav YG, Mondon K, Kalia YN, Novel micelle formulations to increase cutaneous bioavailability of azole antifungals. J Control Release 2011;153:126-32
   PubMed Web of Science ®Google Scholar
• Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 2003;258:141-51
   PubMed Web of Science ®Google Scholar
• Cheow WS, Hadinoto K. Factors affecting drug encapsulation and stability of lipid–polymer hybrid nanoparticles. Colloids Surf B Biointerfaces 2011;85:214-20
   PubMed Web of Science ®Google Scholar
• El laithy HM, El-Shaboury KMF. The development of cutina lipogels and gel microemulsion for topical administration of fluconazole. AAPS PharmSciTech 2002;3:1-9
   Google Scholar
• Murdan S, Gregoriadis G, Florence AT. Novel sorbitan monostearate organogels. J Pharm Sci 1999;88:608-14
   PubMed Web of Science ®Google Scholar
• Salerno C, Carlucci AM, Bregni C. Study of in vitro drug release and percutaneous absorption of fluconazole from topical dosage forms. AAPS PharmSciTech 2010;11:986-93
   PubMed Web of Science ®Google Scholar
• Peira E, Carlotti ME, Trotta C, Positively charged microemulsions for topical application. Int J Pharm 2008;346:119-23
   PubMed Web of Science ®Google Scholar
• Patel MR, Patel RB, Parikh JR, Investigating the effect of vehicle on in vitro skin permeation of ketoconazole applied in O/W microemulsions. Acta Pharmaceutica Sciencia 2010;52:65-77
   Google Scholar
• Dima S, Popescu M. Topical delivery of diclofenac using microemulsion systems. Roumanian Biotech Lett 2008;13:49-55
   Web of Science ®Google Scholar
• Lee EA, Balakrishnan P, Song CK, Microemulsion-based hydrogel formulation of itraconazole for topical delivery. J Pharm Invest 2010;40:305-11
   Google Scholar
• Shah RR, Magdum CS, Patil SS, Niakwade NS. Preparation and evaluation of aceclofenac topical microemulsion. J Pharm Res 2010;9:5-11
   Web of Science ®Google Scholar
• Charles L, Matthew D. Cardiac glycosides for treating muscle pain and spasm. US20030229029; 2003
   Google Scholar
• Hirlekar R, Jain S, Patel M, Hexosomes: a novel drug delivery system. Curr Drug Deliv 2010;7:28-35
   PubMedGoogle Scholar
• Thadanki M, Srivalli P, Prabha K. Overview of cubosomes: a nano particle. Int J Res Pharm Chem 2011;1:535-41
   Google Scholar
• Elisabetta E, Carmelo P, Markus D, Lydia P. Production and characterization of cubosomes: a new tool for percutaneous administration of lipophilic drugs. Proc. 5th world meetings. Pharm Biopharm Pharm Technol 2006;1-2
   Google Scholar
• Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 2004;56:675-711
   PubMed Web of Science ®Google Scholar
• Hofland HEJ, Bouwstra JA, Bodde HE, Interaction between liposomes and human stratum corneum in vitro: freeze fracture electron microscopical visualization and small angle X-ray scattering studies. Br J Dermatol 1995;132:853-66
   PubMed Web of Science ®Google Scholar
• Schaller M, Korting HC. Interaction of liposomes with human skin: the role of the stratum corneum. Adv Drug Deliv Rev 1996;18:303-9
   Web of Science ®Google Scholar
• Foldvari M, Gesztes A, Mezei M. Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. J Microencapsul 1990;7:479-89
   PubMed Web of Science ®Google Scholar
• Korting HC, Zeinicke H, Schafer KM, Falco OB. Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris. Eur J Clin Pharmacol 1990;39:349-51
   PubMed Web of Science ®Google Scholar
• Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. Pharmazie 2007;62:133-7
   PubMed Web of Science ®Google Scholar
• Valenta C, Janisch M. Permeation of cyproterone acetate through pig skin from different vehicles with phospholipids. Int J Pharm 2003;258:133-9
   PubMed Web of Science ®Google Scholar
• Mura S, Manconi M, Sinico C, Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharm 2009;380:72-9
   PubMed Web of Science ®Google Scholar
• Vogt A, Combadiere B, Hadam S, 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol 2006;126:1316-22
   PubMed Web of Science ®Google Scholar
• Manconi M, Caddeo C, Sinico C, Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle–skin interaction. Eur J Pharm Biopharm 2011;78:27-35
   PubMed Web of Science ®Google Scholar
• Verma P, Pathak K. Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomed Nanotechnol Biol Med 2011. doi:10.1016/j.nano.2011.07.004
   Web of Science ®Google Scholar
• Bhalaria MK, Naik S, Misra AN. Ethosomes a novel delivery system for antifungal drug in the treatment of topical fungal diseases. Indian J Exp Biol 2009;47:368-75
   PubMed Web of Science ®Google Scholar
• El Zaafarany GM, Awad GAS, Holayel SM, Mortada ND. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm 2010;397:164-72
   PubMed Web of Science ®Google Scholar
• Kang MJ, Kang MJ, Eum JY, Pep-1 peptide-conjugated elastic liposomal formulation of taxifolin glycoside for the treatment of atopic dermatitis in NC/Nga mice. Int J Pharm 2010;402:198-204
   PubMed Web of Science ®Google Scholar
• Higa Leticia H, Priscila S, Ana PP, Ultradeformable archaeosomes as new topical adjuvants. Nanomed Nanotechnol Biol Med 2012. doi.org/10.1016/j.nano.2012.02.008
   PubMed Web of Science ®Google Scholar
• Cirri M, Bragagni M, Mennini N, Mura P. Development of a new delivery system consisting in ‘‘drug – in cyclodextrin – in nanostructured lipid carriers’’ for ketoprofen topical delivery. Eur J Pharm Biopharm 2012;80:46-53
   PubMed Web of Science ®Google Scholar
• Pople PV, Singh KK. Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis. Int J Pharm 2010;398:165-78
   PubMed Web of Science ®Google Scholar
• Garg A, Singh S. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers. Colloids Surf B Biointerfaces 2011;87:280-8
   PubMed Web of Science ®Google Scholar
• Mitri K, Shegokar R, Gohla S, Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance. Int J Pharm 2011;414:267-75
   PubMed Web of Science ®Google Scholar
• Yordanov G. Influence of the preparation method on the physicochemical properties of econazole-loaded poly (butyl cyanoacrylate) colloidal nanoparticles. Colloids Surf A Physicochem Eng Aspects 2012. doi.org/10.1016/j.colsurfa.2011.12.060
   Google Scholar
• Shah PP, Desai PR, Singh M. Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen. J Control Rel 2012;158:336-45
   PubMed Web of Science ®Google Scholar
• Ourique AF, Melero A, Bona da Silva C, Improved photostability and reduced skin permeation of tretinoin: development of a semisolid nanomedicines. Eur J Pharm Biopharm 2011;79:95-101
   PubMed Web of Science ®Google Scholar
• Filipowicz A, Wołowiec S. Solubility and in vitro transdermal diffusion of riboflavin assisted by PAMAM Dendrimers. Int J Pharm 2011;408:152-6
   PubMed Web of Science ®Google Scholar
• Ali J, Akhtar N, Sultana Y, Antipsoriatic microemulsion gel formulations for topical drug delivery of babchi oil (Psoralea corylifolia). Methods Find Exp Clin Pharmacol 2008;30:277-85
   PubMed Web of Science ®Google Scholar
• Modi JD, Patel JK. Nanoemulsion-based gel formulation of aceclofenac for topical delivery. Int J Pharm Pharm Sci Res 2011;1:6-12
   Google Scholar
• Michael H, Manuela M-G, Barron Annelise E, Sustained prolonged topical delivery of bioactive human insulin for potential treatment of cutaneous wounds. Int J Pharm 2010;398:146-54
   PubMed Web of Science ®Google Scholar
• Baspinar Y, Borchert H. Penetration and release studies of positively and negatively charged nanoemulsions – is there a benefit of the positive charge? Int J Pharm 2012. doi.org/10.1016/j.ijpharm.2012.03.040
   PubMedGoogle Scholar